Jaguar Health, Inc.
JAGX
$2.75
-$0.07-2.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 184.57% | -132.47% | 3.57% | -9.64% | -13.42% |
| Total Depreciation and Amortization | -4.76% | -8.43% | -6.54% | -0.54% | -10.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.49% | 48.13% | -28.56% | 51.52% | -11.40% |
| Change in Net Operating Assets | -201.51% | 970.19% | 1,248.88% | 150.24% | 963.40% |
| Cash from Operations | 220.73% | 29.87% | 26.05% | 24.20% | -3.79% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 106.05% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,603.78% | 0.58% | 9.95% | -54.26% | -7.21% |
| Issuance of Common Stock | -- | -- | 11.30% | -77.75% | -85.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -958.82% | 153.33% | -533.33% | 55.22% | 59.52% |
| Cash from Financing | -233.21% | 245.94% | 77.31% | -78.89% | -59.52% |
| Foreign Exchange rate Adjustments | -52.78% | 82.14% | -732.26% | 670.00% | 289.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 196.54% | 181.74% | 147.48% | -179.51% | -144.44% |